Selenium and experimental cancer.
D019813:1,2-Dimethylhydrazine; D015073:2-Acetylaminofluorene / Q000378:metabolism; D015127:9,10-Dimethyl-1,2-benzanthracene / Q000378:metabolism; D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology; D006224:Cricetinae; D004247:DNA / Q000378:metabolism; D004032:Diet; D004127:Dimethylhydrazines / Q000378:metabolism; D004347:Drug Interactions; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000517:prevention & control; D051379:Mice; D009374:Neoplasms, Experimental / Q000209:etiology / Q000517:prevention & control*; D051381:Rats; D012643:Selenium / Q000008:administration & dosage / Q000172:deficiency / Q000627:therapeutic use*; D014801:Vitamin A / Q000494:pharmacology; D014810:Vitamin E / Q000008:administration & dosage
D004127:Dimethylhydrazines; D014801:Vitamin A; D014810:Vitamin E; D015127:9,10-Dimethyl-1,2-benzanthracene; D004247:DNA; D015073:2-Acetylaminofluorene; D012643:Selenium; D019813:1,2-Dimethylhydrazine; D001205:Ascorbic Acid